Hemostasis Diagnostics Market to account to USD 9.6 billion by 2027 from USD 5.1 billion in 2020 growing at a CAGR of 9.2% in the forecast period.
Usually blood clotting tests are the tests used for diagnostics of the hemostasis system. Coagulometer is the medical laboratory analyzer used for testing of the hemostasis system. Modern coagulometers realize different methods of activation and observation of development of blood clots in blood or in blood plasma.
Major Players in the Hemostasis market are Abbott, Thermo Fisher Scientific, Roche, Nihon, Kohden, Sysmex, Siemens Healthiness, Instrumentation Laboratory, Beckman Coulter, and Grifols.
Coagulation analyzers particularly working on new methods of clot detection, or other novel types of coagulation analyzers are in developments or soon will be ready for use in routine diagnostics of hemostasis disorders new ways of testing in the field of thrombosis and hemostasis may become available. Most of the novel devices we encountered on this journey are small, designed for point-of-care use, in part to maintain lower costs and to use less blood volume. Nevertheless, the new technologies described in this issue of STH could in time be incorporated into larger instruments. Moreover, several of the novel devices offer possible alternative means to study platelet aggregation, a laboratory test procedure that is currently complex and time-consuming to perform.
In July 2020, Sysmex Corporation launched of new products in the hemostasis field: the Automated Blood Coagulation Analyzers CN-6500/CN-3500. These new offerings from Sysmex come with a measuring unit using the chemiluminescence enzyme immunoassay methodology (CLEIA), which we cultivated in our Automated Immunoassay Systems HISCL-5000/HISCL-800 (HISCL), on top of the unique features of the Automated Blood Coagulation Analyzers CN-6000/CN-3000, making it possible to measure blood coagulation testing parameters, including molecular markers for blood coagulation with a single device.
Instrumentation Laboratory (IL) has received three IMV ServiceTrak Awards for 2020, including Best System Performance, for the second consecutive year, Best Service in the Coagulation category, and Best Customer Satisfaction, in the newly added Blood Gas category. These honors reflect excellence across IL's innovative Hemostasis and Acute Care Diagnostics product portfolios, as well as the Company's support of customers.
The Global Hemostasis Diagnostics market divided by product types including, Prothrombin Test Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen, Degradation Products (FDP), Activated Clotting Time, Platelet Aggregation Test, D Dimer. Hemostasis Diagnostics market segregation by applications are Hospital/Clinics, Independent Diagnostic Laboratories, Home Care Settings. North America is expected to dominate the global hemostasis diagnostics market over the forecast timeline, owing to the presence of developed countries, such as the U.S. and Canada, increased prevalence of hemostasis disorders, and advanced healthcare facilities and infrastructure are expected to promote the growth of hemostasis diagnostics market over the forecast timeline.
For more information contact @